NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 107 filers reported holding NOVOCURE LTD in Q3 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,882,449 | -14.7% | 109,892 | -22.1% | 0.00% | – |
| Q1 2024 | $2,205,955 | +40.6% | 141,136 | +34.3% | 0.00% | – |
| Q4 2023 | $1,569,441 | -47.6% | 105,120 | -43.3% | 0.00% | -100.0% |
| Q3 2023 | $2,996,035 | -53.4% | 185,513 | +19.6% | 0.00% | -50.0% |
| Q2 2023 | $6,435,698 | -29.5% | 155,077 | +2.2% | 0.00% | -33.3% |
| Q1 2023 | $9,126,367 | -17.2% | 151,752 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $11,018,710 | +76.6% | 150,221 | +82.9% | 0.00% | +50.0% |
| Q3 2022 | $6,240,000 | +4.1% | 82,134 | -4.8% | 0.00% | 0.0% |
| Q2 2022 | $5,994,000 | +2.9% | 86,255 | +22.6% | 0.00% | +100.0% |
| Q1 2022 | $5,826,000 | +28.6% | 70,328 | +16.5% | 0.00% | 0.0% |
| Q4 2021 | $4,531,000 | -73.6% | 60,342 | -59.1% | 0.00% | -75.0% |
| Q3 2021 | $17,136,000 | -68.4% | 147,502 | -39.7% | 0.00% | -69.2% |
| Q2 2021 | $54,289,000 | +228.8% | 244,744 | +95.9% | 0.01% | +225.0% |
| Q1 2021 | $16,512,000 | +45.2% | 124,915 | +90.0% | 0.00% | +33.3% |
| Q4 2020 | $11,374,000 | +524.9% | 65,730 | +302.0% | 0.00% | +200.0% |
| Q3 2020 | $1,820,000 | +13.0% | 16,350 | -39.8% | 0.00% | 0.0% |
| Q2 2020 | $1,611,000 | -96.5% | 27,179 | -96.1% | 0.00% | -95.0% |
| Q1 2020 | $46,509,000 | -42.6% | 690,657 | -28.1% | 0.02% | -20.0% |
| Q4 2019 | $81,002,000 | +92.2% | 961,222 | +70.5% | 0.02% | +127.3% |
| Q3 2019 | $42,150,000 | +11.2% | 563,658 | -6.0% | 0.01% | +10.0% |
| Q2 2019 | $37,903,000 | +109.2% | 599,437 | +59.4% | 0.01% | +66.7% |
| Q1 2019 | $18,116,000 | +157.3% | 376,085 | +78.9% | 0.01% | +100.0% |
| Q4 2018 | $7,040,000 | -58.9% | 210,270 | -35.7% | 0.00% | -40.0% |
| Q3 2018 | $17,148,000 | +460.2% | 327,257 | +234.6% | 0.01% | +400.0% |
| Q2 2018 | $3,061,000 | +65.5% | 97,810 | +15.3% | 0.00% | 0.0% |
| Q1 2018 | $1,849,000 | -63.1% | 84,795 | -65.8% | 0.00% | -50.0% |
| Q4 2017 | $5,008,000 | +49.5% | 247,924 | +47.0% | 0.00% | +100.0% |
| Q3 2017 | $3,349,000 | – | 168,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
| Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
| COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
| GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
| HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
| Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
| Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
| Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |